Search details
1.
The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function.
J Immunol
; 202(5): 1397-1405, 2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30692213
2.
T-cell co-stimulation through the CD2 and CD28 co-receptors induces distinct signalling responses.
Biochem J
; 460(3): 399-410, 2014 Jun 15.
Article
in English
| MEDLINE | ID: mdl-24665965
3.
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.
J Virol
; 85(13): 6557-66, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21490090
4.
Protein kinase A antagonist inhibits ß-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min/+) mice.
Mol Cancer
; 10: 149, 2011 Dec 15.
Article
in English
| MEDLINE | ID: mdl-22168384
5.
A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.
Eur J Immunol
; 40(1): 134-41, 2010 Jan.
Article
in English
| MEDLINE | ID: mdl-19877008
6.
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population.
Eur J Immunol
; 39(5): 1280-7, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19384871
7.
LPS-activated monocytes suppress T-cell immune responses and induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism.
Int Immunol
; 20(2): 235-45, 2008 Feb.
Article
in English
| MEDLINE | ID: mdl-18156149
8.
Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation.
J Leukoc Biol
; 83(5): 1111-7, 2008 May.
Article
in English
| MEDLINE | ID: mdl-18270250
9.
Human regulatory T cells control TCR signaling and susceptibility to suppression in CD4+ T cells.
J Leukoc Biol
; 100(1): 5-16, 2016 07.
Article
in English
| MEDLINE | ID: mdl-26715685
10.
Regulatory T cells that co-express RORγt and FOXP3 are pro-inflammatory and immunosuppressive and expand in human pancreatic cancer.
Oncoimmunology
; 5(4): e1102828, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27141387
11.
CD4+CD25+ regulatory T cells in HIV infection.
Microbes Infect
; 7(7-8): 1063-5, 2005 Jun.
Article
in English
| MEDLINE | ID: mdl-15893493
12.
New observations on CD8 cell responses.
AIDS
; 17 Suppl 4: S61-5, 2003.
Article
in English
| MEDLINE | ID: mdl-15080181
13.
Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy.
AIDS
; 18(6): 951-2, 2004 Apr 09.
Article
in English
| MEDLINE | ID: mdl-15060445
14.
Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner.
Cancer Immunol Immunother
; 57(6): 813-21, 2008 Jun.
Article
in English
| MEDLINE | ID: mdl-17962941
15.
Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin.
J Immunol
; 179(8): 5159-68, 2007 Oct 15.
Article
in English
| MEDLINE | ID: mdl-17911601
16.
FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism.
J Immunol
; 177(1): 246-54, 2006 Jul 01.
Article
in English
| MEDLINE | ID: mdl-16785520
17.
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.
J Virol
; 78(5): 2454-9, 2004 Mar.
Article
in English
| MEDLINE | ID: mdl-14963140
18.
CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets.
J Immunol
; 170(5): 2349-55, 2003 Mar 01.
Article
in English
| MEDLINE | ID: mdl-12594257
19.
A winged helix forkhead (FOXD2) tunes sensitivity to cAMP in T lymphocytes through regulation of cAMP-dependent protein kinase RIalpha.
J Biol Chem
; 278(19): 17573-9, 2003 May 09.
Article
in English
| MEDLINE | ID: mdl-12621056
20.
Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
Blood
; 104(12): 3672-8, 2004 Dec 01.
Article
in English
| MEDLINE | ID: mdl-15308569